Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus

Journal of Diabetes Investigation
Ki Ho SongYu-Bae Ahn

Abstract

We aimed to investigate whether there are differences in the risk factors or markers for the progression of diabetic retinopathy (DR) and diabetic nephropathy (DN) in type 2 diabetes mellitus. We carried out a 3-year retrospective cohort study of 604 patients with type 2 diabetes mellitus. The outcomes were the progression of DR (worsening of the DR stage) and DN (an estimated glomerular filtration rate decline >12%) at the 3-year follow up. The mean hemoglobin A1c (HbA1c) level and HbA1c variability (HbA1c-VAR) were calculated. The mean HbA1c and HbA1c-VAR levels were higher in the DR progressors (n = 67) than in the DR non-progressors (n = 537). The mean HbA1c was a significant predictor for DR progression independent of the duration of diabetes and HbA1c-VAR levels. The urine albumin-to-creatinine ratio at baseline and HbA1c-VAR levels were higher in the DN progressors (n = 34) than in the DN non-progressors (n = 570). The triglyceride to high-density lipoprotein cholesterol ratio at baseline tended to be higher in the DN progressors than in the DN non-progressors. HbA1c-VAR levels and the triglyceride-to-high-density lipoprotein cholesterol ratio were significant predictors for DN progression independent of estimated glomer...Continue Reading

References

May 22, 2002·JAMA : the Journal of the American Medical Association·Joshua A BeckmanPeter Libby
Sep 18, 2003·Ophthalmology·C P WilkinsonUNKNOWN Global Diabetic Retinopathy Project Group
Dec 25, 2003·Diabetes Care·Donald S FongUNKNOWN American Diabetes Association
Mar 9, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jean-Claude AnsquerUNKNOWN DAIS Investigators
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Louis MonnierClaude Colette
Aug 16, 2006·Annals of Internal Medicine·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
May 11, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·M A IhnatA Ceriello
Dec 17, 2008·Clinical Science·Fatiha Tabet, Kerry-Anne Rye
Feb 7, 2009·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·G ZoppiniM Muggeo
Aug 29, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Hiroki YokoyamaMasakazu Haneda
Jul 1, 2010·The New England Journal of Medicine·UNKNOWN ACCORD Study GroupLawrence J Fine
Sep 10, 2010·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Nosratola D Vaziri
Nov 6, 2010·Diabetologia·T M E DavisUNKNOWN Fenofibrate Intervention and Event Lowering in Diabetes Study investigators
Jan 28, 2012·Clinical Journal of the American Society of Nephrology : CJASN·Giacomo ZoppiniEnzo Bonora
Aug 15, 2012·Diabetes Care·Jamie MortonUNKNOWN ADVANCE Collaborative Group
Aug 24, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·S Rodríguez-SegadeF Camiña
Jan 2, 2013·Journal of Diabetes and Its Complications·I Te LeeWayne H H Sheu
Aug 6, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·C K Kramer, R Retnakaran
Sep 25, 2014·Diabetes Care·Katherine R TuttleMark E Molitch
Apr 5, 2016·Journal of Diabetes·Valencia FooCharumathi Sabanayagam
Feb 23, 2017·Diabetes Care·Sharon D SolomonThomas W Gardner
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Jan 23, 2020·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Lijun ZhaoFang Liu
Feb 20, 2020·Current Opinion in Endocrinology, Diabetes, and Obesity·Masha G SavelieffEva L Feldman
Jul 6, 2020·Cardiovascular Diabetology·Zheng ZhouMeng Bian
Mar 19, 2020·Journal of Clinical Pathology·Glaucia VeigaFernando Fonseca
Oct 9, 2020·Journal of Diabetes Investigation·Kenichi Shikata
Dec 15, 2020·Journal of Diabetes Investigation·Kuan-Yu LinTien-Jyun Chang
Oct 30, 2020·Antioxidants·Fatima Tuj JohraHasan Mahmud Reza
Jun 6, 2020·Diabetes Research and Clinical Practice·Ilias N MigdalisUNKNOWN Hellenic Diabetic Nephropathy Study (HDNS) Group
Jun 3, 2021·Journal of Clinical Medicine·Ilias N Migdalis On Behalf Of The Hellenic Diabetic Nephropathy Study Hdns
Sep 8, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Ketan DhatariyaIan Nunney

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.